Literature DB >> 20696691

Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010.

Mark E Roberts1, Edmund Neville, Richard G Berrisford, George Antunes, Nabeel J Ali.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20696691     DOI： 10.1136/thx.2010.136994

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  195 in total

1.  The importance of a satisfactory biopsy for the diagnosis of lung cancer in the era of personalized treatment.

Authors:  L M Ofiara; A Navasakulpong; N Ezer; A V Gonzalez
Journal:  Curr Oncol       Date:  2012-06       Impact factor: 3.677

Review 2.  From "awake" to "monitored anesthesia care" thoracic surgery: A 15 year evolution.

Authors:  Tommaso C Mineo; Federico Tacconi
Journal:  Thorac Cancer       Date:  2014-01-02       Impact factor: 3.500

Review 3.  Switching off malignant pleural effusion formation-fantasy or future?

Authors:  Magda Spella; Anastasios D Giannou; Georgios T Stathopoulos
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

4.  Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT.

Authors:  Rahul Bhatnagar; Ramon Luengo-Fernandez; Brennan C Kahan; Najib M Rahman; Robert F Miller; Nick A Maskell
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

5.  Mortality among patients with pleural effusion undergoing thoracentesis.

Authors:  Erin M DeBiasi; Margaret A Pisani; Terrence E Murphy; Katy Araujo; Anna Kookoolis; A Christine Argento; Jonathan Puchalski
Journal:  Eur Respir J       Date:  2015-04-02       Impact factor: 16.671

Review 6.  Diagnosis and management of malignant pleural effusions: state of the art in 2017.

Authors:  Neeraj R Desai; Hans J Lee
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

7.  Sodium hydroxide as a sclerosing agent in patients with neoplastic pleural effusion non-candidates for VATS: results of a minimally invasive protocol.

Authors:  Micaela Raices; Matías E Czerwonko; Agustin Dietrich; Alejandro Da Lozzo; Enrique Beveraggi; David Smith
Journal:  Updates Surg       Date:  2017-08-31

8.  Quality Gaps and Comparative Effectiveness of Management Strategies for Recurrent Malignant Pleural Effusions.

Authors:  David E Ost; Jiangong Niu; Hui Zhao; Horiana B Grosu; Sharon H Giordano
Journal:  Chest       Date:  2017-08-31       Impact factor: 9.410

Review 9.  Update in hospital palliative care.

Authors:  Wendy G Anderson; Lynn A Flint; Jay R Horton; Kimberly Johnson; Michelle Mourad; Bradley A Sharpe
Journal:  J Hosp Med       Date:  2013-11-08       Impact factor: 2.960

10.  Mast cells mediate malignant pleural effusion formation.

Authors:  Anastasios D Giannou; Antonia Marazioti; Magda Spella; Nikolaos I Kanellakis; Hara Apostolopoulou; Ioannis Psallidas; Zeljko M Prijovich; Malamati Vreka; Dimitra E Zazara; Ioannis Lilis; Vassilios Papaleonidopoulos; Chrysoula A Kairi; Alexandra L Patmanidi; Ioanna Giopanou; Nikolitsa Spiropoulou; Vaggelis Harokopos; Vassilis Aidinis; Dionisios Spyratos; Stamatia Teliousi; Helen Papadaki; Stavros Taraviras; Linda A Snyder; Oliver Eickelberg; Dimitrios Kardamakis; Yoichiro Iwakura; Thorsten B Feyerabend; Hans-Reimer Rodewald; Ioannis Kalomenidis; Timothy S Blackwell; Theodora Agalioti; Georgios T Stathopoulos
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.